Working with you to combat SARS-CoV-2
From synthetic DNA parts to full-length synthetic genomes, Telesis Bio is working with you to combat SARS-CoV-2.
Our SARS-CoV-2 tools are built with Gibson Assembly® technology, and are delivered to you in as little as a week, helping you to accelerate SARS-CoV-2 research with unprecedented speed and scale.
Synthetic DNA parts
Custom design double-stranded synthetic DNA parts spanning the whole SARS-CoV-2 genome — useful for developing DNA, RNA, and viral vector vaccines and pan-genome diagnostics. Available in lengths of 300 to 5,000 bp.
Antigen expression panels
Rapidly design and iterate antigen panels (e.g., spike protein) for vaccine development. Cloning into custom vectors is available.
Antibody expression libraries
Expertly design and generate SARS-CoV-2 antibody expression libraries for the development of therapeutics. A wide choice of library types is available, including site saturation, alanine scanning, combinatorial degenerate variant libraries, and combinatorial codon-controlled variant libraries. Cloning into custom vectors is available.
Spike protein vaccine scaffold
Our dedicated COVID-19 team can help you clone wild-type, spike protein gene fragments, or clone synthetic DNA parts into the DNA vaccine vector of your choice.
Full-length synthetic genome
Create modified versions of our commercially available SARS-CoV-2 full-length, synthetic genomes.
Live attenuated vaccine scaffold
Leverage our full-length, synthetic SARS-CoV-2 genome for the development of live attenuated vaccines.